Tanshinone IIA attenuates elastase-induced AAA in rats via inhibition of myD88-dependent TLR-4 signaling;Tanshinone IIA schwächt das elastase-induzierte bauch-aortenaneurysma in ratten über eine hemmung der myD88-abhängige TLR-4 signalsierung ab

Vasa - Journal of Vascular Diseases

Volumn 43, Issue 1, 2014, Pages 39-46

  Shang, Tao ^a   Ran, Feng ^a   Qiao, Qian ^b   Liu, Zhao ^a   Liu, Chang Jian ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Abdominal aortic aneurysm; Myeloid differentiation factor; Nuclear factor b; Tanshinone IIa; Toll like receptor

Indexed keywords

EID: 84892567090     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000326     Document Type: Article

References (37)

1. Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, Gelijns AC, Greco G. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg. 2010; 52: 539-548.
2. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneu-rysm Trial Participants. Lancet. 1998; 352: 1649-1655.
3. Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, Ballard DJ, Messina LM, Gordon IL, Chute EP, Krupski WC, Bu-suttil SJ, Barone GW, Sparks S, Graham LM, Rapp JH, Makaroun MS, Moneta GL, Cambria RA, Makhoul RG, Eton D, Ansel HJ, Freischlag JA, Bandyk D; Aneurysm Detection and Management Veterans Af airs Cooperative Study Group. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002; 346: 1437-1444.
4. Shang T, Liu Z, Zhou M, Zarins CK, Xu C, Liu CJ. Inhibition of experimental abdominal aortic aneurysm in a rat model by way of tanshinone IIA. J. Surg Res. 2012; 178: 1029-1037.
5. Feng CG, Scanga CA, Collazo-Custodio CM, Cheever AW, Hieny S, Caspar P, Sher A. Mice lacking myeloid dif erentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR-2) and TLR-4 def cient animals. J. Immunol. 2003; 171: 4758-4764.
6. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006; 117: 979-987.
7. Ren ZH, Tong YH, Xu W, Ma J, Chen Y. Tanshinone IIA attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression. Phyto-medicine. 2010; 17: 212-218.
8. Silence J, Lupu F, Collen D, Lijnen HR. Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Strome-lysin-1 (MMP-3) Gene Inactiva-tion. Arterioscler T romb Vasc Biol. 2001; 21: 1440-1445.
9. Tanga FY, Raghavendra V, DeLeo JA. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochemistry International. 2004; 45: 397-407.
10. Oliva J, Bardag-Gorce F, Li J, French BA, French SW. S-adenosylmethio-nine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in rats. Exp Mol Pathol. 2011; 90: 239-243.
11. Hishikawa K, Oemar BS, Yang Z, Lüscher TF. Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. Circ Res. 1997; 81: 797-803.
12. Periard D, Guessous I, Mazzolai L, Haesler E, Monney P, Hayoz D. Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins.Vasa. 2012; 41: 35-42.
13. Tompson RW, Curci JA, Ennis TL, Mao D, Pagano MB, Pham CT. Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with dif erent genetic backgrounds. Ann. NY Acad. Sci. 2006; 1085: 59-73.
14. Steinmetz EF, Buckley C, Shames ML, Ennis TL, Vanvickle-Chavez SJ, Mao D, Goeddel LA, Hawkins CJ, Tompson RW. Treatment With Simvastatin Suppresses the Development of Experimental Abdominal Aortic Aneurysms in Normal and Hypercholesterol-emic Mice. Ann Surg. 2005; 241: 92-101.
15. Shiraya S, Miyake T, Aoki M, Yo-shikazu F, Ohgi S, Nishimura M, Ogihara T, Morishita R. Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. Atherosclerosis. 2009; 202: 34-40.
16. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic an-eurysms. J Clin Invest. 2002; 110: 625-632.
17. Diehm N, Becker G, Katzen B, Ben-enati J, Kovacs M, Dick F. Statins are associated with decreased mortality in abdominal, but not in thoracic aortic aneurysm patients undergoing endovascular repair: propensity score-adjusted analysis. Vasa. 2008; 37: 241-249.
18. Miller FJ Jr, Sharp WJ, Fang X, Oberley LW, Oberley TD, Wein-traub NL. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler T romb Vasc Biol. 2002; 22: 560-565.
19. Teng X, Zhang H, Snead C, Catra-vas JD. Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells. Am J Physiol Cell Physiol. 2002; 282: 144-152.
20. Liapis CD, Paraskevas KI. T e pivotal role of matrix metalloprotein-ases in the development of human abdominal aortic aneurysms. Vasc Med. 2003; 8: 267-271.
21. Nakashima H, Aoki M, Miyake T, Kawasaki T, Iwai M, Jo N, Oishi M, Kataoka K, Ohgi S, Ogihara T, Kaneda Y, Morishita R. Inhibition of Experimental Abdominal Aortic Aneurysm in the Rat by Use of Decoy Oligodeoxynucleotides Suppressing Activity of Nuclear Factor κB and ets Transcription Factors. Circulation. 2004; 109: 132-138.
22. Karin M, Ben-Neriah Y. Phosphor-ylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 2000; 18: 621-663.
23. Fusco AJ, Huang DB, Miller D, Wang VY, Vu D, Ghosh G. NF-kappaB p52: RelB heterodimer recognizes two classes of kappaB sites with two distinct modes. EMBO Rep. 2009; 10: 152-159.
24. Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 2007; 8: 49-62.
25. Waterhouse RM, Kriventseva EV, Meister S, Xi Z, Alvarez KS, Bar-tholomay LC, Barillas-Mury C, Bian G, Blandin S, Christensen BM, Dong Y, Jiang H, Kanost MR, Koutsos AC, Levashina EA, Li J, Ligoxygakis P, Maccallum RM, Mayhew GF, Mendes A, Michel K, Osta MA, Paskewitz S, Shin SW, Vlachou D, Wang L, Wei W, Zheng L, Zou Z, Severson DW, Raikhel AS, Kafatos FC, Dimopoulos G, Zdobnov EM, Christophides GK. Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes. Science. 2007; 316: 1738-1743.
26. Gilmore TD. Introduction to NF-κB: players, pathways, perspectives. Oncogene. 2006; 25: 6680-6684.
27. Brasier AR. The NF-kappaB regulatory network. Cardiovasc. Toxicol. 2006; 6: 111-130.
28. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001; 1: 135-45.
29. Takeda K, Kaisho T, Akira S. Tolllike receptors. Annu Rev Immunol. 2003; 21: 335-76.
30. Owens AP 3rd, Rateri DL, Howatt DA, Moore KJ, Tobias PS, Curtiss LK, Lu H, Cassis LA, Daugherty A. MyD88 Def ciency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Independent of Signaling through Toll-Like Receptors 2 and 4. Arte-rioscler T romb Vasc Biol. 2011; 31: 2813-2819.
31. Biros E, Walker PJ, Nataatmadja M, West M, Golledge J. Downregula-tion of transforming growth factor, beta receptor2 and Notch signaling pathway in human abdominal aortic aneurysm. Atherosclerosis. 2012; 221: 383-386.
32. Yamanouchi D, Morgan S, Kato K, Lengfeld J, Zhang F, Liu B. Effects of Caspase Inhibitor on Angioten-sin II-Induced Abdominal Aortic Def cient Mice-Aneurysm in Apo-lipoprotein E. Arterioscler T romb Vasc Biol. 2010; 30: 702-707.
33. Hans CP, Koenig SN, Huang N, Cheng J, Beceiro S, Guggilam A, Kuivaniemi H, Partida-Sánchez S, Garg V. Inhibition of Notch1 Signaling Reduces Abdominal Aortic Aneurysm in Mice by Attenuating Macrophage-Mediated Inf amma-tion. Arterioscler T romb Vasc Biol. 2012; 32: 3012-3023.
34. Haddad JJ, Abdel-Karim NE. NF-κB cellular and molecular regulatory mechanisms and pathways: T era-peutic pattern or pseudoregulation? Cellular Immunology.2011; 271: 5-14.
35. Miyake T, Aoki M, Masaki H, Kawasaki T, Oishi M, Kataoka K, Ogihara T, Kaneda Y, Morishita R. Regression of Abdominal Aortic Aneurysms by Simultaneous Inhibition of Nuclear Factor κB and Ets in a Rabbit Model. Circulation Research. 2007; 101: 1175-1184.
36. Piechota-Polanczyk A, Goraca A, Demyanets S, Mittlboeck M, Domenig C, Neumayer C, Wojta J, Nanobachvili J, Huk I, Klinger M. Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB. Eur J Vasc Endovasc Surg. 2012; 44: 133-137.
37. Tanaka A, Hasegawa T, Chen Z, Okita Y, Okada K. A novel rat model of abdominal aortic aneu-rysm using a combination of in-traluminal elastase infusion and extraluminal calcium chloride exposure. J Vasc Surg. 2009; 50: 1423-1432.